Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
Ana Martinez-NaharroRishi K PatelTushar KotechaNina KariaAdam IoannouAviva PetrieLiza A ChackoYousuf RazviSriram RavichandranJames BrownSteven LawCandida Cristina QuartaShameem MahmoodBrendan WisniowskiSilvia PicaSajitha SachchithananthamHelen J LachmannJames C MoonDaniel S KnightCarol WhelanLucia VenneriHui XuePeter KellmanJulian David GillmorePhilip N HawkinsAshutosh D WechalekarMarianna FontanaPublished in: European heart journal (2022)
Cardiac amyloid deposits frequently regress following chemotherapy, but only in patients who achieve CR or VGPR. Changes in ECV predict outcome after adjusting for known predictors.